Trial intelligence / Profile preview

Preotact vs Alendronate for Back Pain in Osteoporosis

NCT00713258Phase 4Terminated

Sponsor
Nycomed
Start
Apr 2008
Primary completion
May 2010
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 4 trial of parathyroid hormone 1-84 in osteoporosis, sponsored by Nycomed. Started Apr 2008; status: terminated.

02

Drugs

parathyroid hormone 1-84
03

Conditions

osteoporosis

Beyond the preview

Go deeper on NCT00713258.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00713258.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call